1. Home
  2. ADBE vs PFE Comparison

ADBE vs PFE Comparison

Compare ADBE & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adobe Inc.

ADBE

Adobe Inc.

N/A

Current Price

$219.27

Market Cap

91.7B

Sector

Technology

ML Signal

N/A

Logo Pfizer Inc.

PFE

Pfizer Inc.

N/A

Current Price

$27.53

Market Cap

161.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ADBE
PFE
Founded
1982
1849
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.7B
161.2B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ADBE
PFE
Price
$219.27
$27.53
Analyst Decision
Hold
Hold
Analyst Count
39
28
Target Price
★ $266.91
$30.22
AVG Volume (30 Days)
3.4M
★ 24.3M
Earning Date
12-09-2026
11-03-2026
Dividend Yield
N/A
★ 6.25%
EPS Growth
★ 35.11
N/A
EPS
★ 13.47
0.99
Revenue
$23,769,000,000.00
★ $62,579,000,000.00
Revenue This Year
$11.94
$0.88
Revenue Next Year
$9.13
N/A
P/E Ratio
★ $16.45
$27.85
Revenue Growth
★ 10.53
N/A
52 Week Low
$190.12
$23.62
52 Week High
$362.71
$31.44

Technical Indicators

Market Signals
Indicator
ADBE
PFE
Relative Strength Index (RSI) 31.91 34.06
Support Level $210.88 $26.68
Resistance Level $245.30 $27.75
Average True Range (ATR) 8.01 0.70
MACD -2.57 -0.31
Stochastic Oscillator 2.65 1.25

Price Performance

Historical Comparison
ADBE
PFE

About ADBE Adobe Inc.

Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).

About PFE Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Share on Social Networks: